NSE: MAXHEALTH · 21 October 2026
- MAX HEALTHCARE INS LTD (MAXHEALTH) is trading down 0.43% at ₹826.45, moving within a day's range of ₹825.30 to ₹837.85 after opening slightly higher at ₹834.90.
- Max Healthcare Institute Limited announced the scrutinizer's report and voting results for its postal ballot conducted via remote e-voting from September 20 to October 19, 2026. Members approved the Performance Linked Restricted Stock Unit Scheme 2026, the grant of PRSUs to eligible employees of the company and its subsidiaries, the remuneration payable to Chairman and Managing Director Mr. Abhay Soi, and the alteration of the Main Objects Clause of the Memorandum of Association.
- Trading volume was 0.25 times the 20-day average daily volume.
Why is Max Healthcare Ins share price falling on 21 October 2026?
MAX HEALTHCARE INS LTD (MAXHEALTH) is trading down 0.43% at ₹826.45, moving within a day's range of ₹825.30 to ₹837.85 after opening slightly higher at ₹834.90.
The stock's minor dip aligns with a softer tone in the broader healthcare space, as the sectoral benchmark Nifty Pharma declined 0.51%, while the broader Nifty index managed a positive gain of 0.36%. MAXHEALTH's move reflects ongoing consolidation after a challenging recent stretch, underscored by a 20-day return of -22.52% and a 5-day return of -4.01%.
Company disclosures from October 19, 2026, highlighted that shareholders approved the Performance Linked Restricted Stock Unit Scheme 2026 alongside an amendment to the Memorandum of Association during a postal ballot. While these corporate governance updates provide context on long-term capital and incentive structures, they appear to have had a neutral-to-muted direct impact on today's minor price adjustment.
8.04 lakh shares traded by 21 October 2026 · 11:00 AM IST. This compares with a 20-day average daily volume of 32.50 lakh shares (0.25 times). The five-day average daily volume was 31.28 lakh shares. Separately, the NSE report for 19 October 2026 showed 10.54 lakh shares delivered, representing 51.58% of that day’s traded volume. The same report recorded 48,522 trades.
The stock's modest pullback of 0.43% occurs on thin trading volumes (0.25x of 20-day average volume) alongside a softer Nifty Pharma sector. Recent corporate updates regarding employee incentive schemes and memorandum amendments provide structural context but lack direct intraday catalysts, making the move primarily a reflection of broader sectoral consolidation.
Latest Company Developments
Max Healthcare Institute Limited announced the scrutinizer's report and voting results for its postal ballot conducted via remote e-voting from September 20 to October 19, 2026. Members approved the Performance Linked Restricted Stock Unit Scheme 2026, the grant of PRSUs to eligible employees of the company and its subsidiaries, the remuneration payable to Chairman and Managing Director Mr. Abhay Soi, and the alteration of the Main Objects Clause of the Memorandum of Association.
These approvals establish key long-term incentive frameworks and expand the operational scope of the company's business objects.
The company received an intimation from NSE Sustainability Ratings and Analytics Limited informing that an independent ESG rating of '66' had been assigned for the financial year 2025-26 based on public disclosures. The company clarified that it had not formally engaged the provider for this rating.
Provides an external benchmark of the company's sustainability and governance disclosure standards.
CARE Ratings Limited upgraded and reaffirmed credit ratings for material subsidiary Crosslay Remedies Limited across various bank facilities, assigning a CARE AA+; Stable rating. The company also announced a reaffirmation of its own standalone bank credit facilities at CARE AA+; Stable and CARE A1+ on October 9, 2026.
Reinforces the credit profile and borrowing capacity of both the parent entity and its key subsidiary.
disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Max Healthcare Institute Limited has submitted the Exchange a copy Scrutinizers report of Postal Ballot. Further, the Company has informed the Exchange regarding voting results.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 19.25% on 30 September 2026. This compares with 18.68% on 30 June 2026, a change of +0.57 percentage points.
The filing reported 40 MF/UTI holders.
What to Watch Next
- Execution and implementation timelines for the newly approved Performance Linked Restricted Stock Unit Scheme 2026
- Developments regarding the expansion of business objects under the amended Memorandum of Association
- Volume participation relative to the 20-day average volume of approximately 0.25x
- Delivery percentage trends following the recent delivery rate of 51.58% recorded on October 19, 2026 across 48,522 trades
Other Dated Coverage
- Max Healthcare Ins Share Price Today: Why MAXHEALTH Is Falling 2.81% | 13 October 2026 — 13 October 2026
- Why MAXHEALTH Shares Fell 1.58% Today: Sector Divergence Explored | 6 October 2026 — 6 October 2026
- Why Max Healthcare Shares Fell 2.55% Today: Sector Weakness & Pullback | 5 October 2026 — 5 October 2026
More Max Healthcare Ins news and dated analysis →
Frequently Asked Questions
What is the latest Max Healthcare Ins company news?
Max Healthcare Institute Limited announced the scrutinizer's report and voting results for its postal ballot conducted via remote e-voting from September 20 to October 19, 2026. Members approved the Performance Linked Restricted Stock Unit Scheme 2026, the grant of PRSUs to eligible employees of the company and its subsidiaries, the remuneration payable to Chairman and Managing Director Mr. Abhay Soi, and the alteration of the Main Objects Clause of the Memorandum of Association.
How strong was Max Healthcare Ins’s trading volume?
8.04 lakh shares traded, 0.25 times the 20-day average daily volume. The price and volume data are dated 21 October 2026 · 11:00 AM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.